| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.016 | 32.868 | 18.823 | 13.871 | 6.233 | 9.577 | 7.159 | 5.479 | 23.409 | 23.577 |
| Total Income - EUR | 21.021 | 32.972 | 18.831 | 13.896 | 7.076 | 9.584 | 7.159 | 5.479 | 23.423 | 23.579 |
| Total Expenses - EUR | 9.968 | 28.796 | 3.981 | 19.195 | 10.575 | 8.495 | 5.235 | 2.024 | 8.547 | 15.585 |
| Gross Profit/Loss - EUR | 11.054 | 4.176 | 14.850 | -5.299 | -3.499 | 1.089 | 1.924 | 3.456 | 14.876 | 7.994 |
| Net Profit/Loss - EUR | 10.423 | 3.187 | 14.285 | -5.480 | -3.570 | 886 | 1.735 | 3.291 | 12.496 | 6.032 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Homeostudy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 598 | 269 | 391 | 113 | 0 | 0 | 0 | 713 | 571 | 429 |
| Current Assets | 10.131 | 3.496 | 17.410 | 11.354 | 6.144 | 6.527 | 5.767 | 8.047 | 13.919 | 8.023 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 10 | 39 | 0 | 0 | 0 | 45 | 0 | 8.324 | 0 |
| Cash | 10.131 | 3.486 | 17.371 | 11.354 | 6.144 | 6.527 | 5.721 | 8.047 | 5.595 | 8.023 |
| Shareholders Funds | 10.468 | 3.305 | 17.534 | 7.005 | 3.299 | 4.123 | 5.767 | 9.076 | 12.755 | 6.676 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 261 | 460 | 267 | 4.462 | 2.845 | 2.404 | 0 | 39 | 1.735 | 1.917 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Homeostudy Srl